North America Diabetes Care Devices Market to grow at a CAGR of 5.08% during 2015 to 2020

The North America Diabetes Care Devices Market has been estimated at USD 7.281 billion in 2015 and is projected to reach USD 9.328 billion by 2020, at a CAGR of 5.08% during the forecast period from 2015 to 2020.Diabetes is a group of metabolic disorders, chronic condition which is associated with abnormally high level of sugar (glucose) in the blood. North America currently witnesses 44.3 million people affected with Diabetes which is going to reach 60.5 million by 2040.

In North America, due to the increasing incidence of chronic diseases and over adoption of sedentary lifestyle, people are severely prone to become obese and get affected with Diabetes. With the increase in number of patients, there is a growing demand for diabetes care devices, which is driving the market.

Browse market data tables and in-depth TOC of the North America Diabetes Care Devices Market to 2021 @

Also, due to the increasing R & D in Diabetes Care Devices technologies, the market is progressing.  Reimbursement and patent expiry are the two issues that are constraining the market. Maximizing patent term for successful products is an effective strategy for staying away from competition and extending product sales in North America.

In North America, the diabetes care device market is segmented by type and by country. By type the market has been segmented in to Insulin delivery devices, Diabetes monitoring devices and Diabetes Control Solutions. The products in each of these segments are segregated in the following way: Diabetes Monitoring Devices (Self-blood Monitoring Devices: Blood Glucose Monitoring Devices, Test Strips, Lancets and Hemoglobin A1c Testing Kits; Continuous Glucose Monitoring Devices); Insulin Delivery Devices (Insulin Pens, Insulin Pumps, Jet Injectors and Insulin Syringes) and Diabetes Control Solutions.

Free sample of the report is available @

Geographically, North America is segmented into USA and Canadian markets. North America tops the global market with USA contributing maximum to the North American market share. Many top companies are based in North America, due to which it contributes to the majority of market share. National Diabetes Prevention program by U.S Department of Health & Human Services, is a public-private partnership of community organizations, private insurers, employers, government agencies and health care organizations. They work for establishing local evidence-based lifestyle change programs for people at higher risk for type 2 diabetes. In this way, the private companies partnering with public sector will create a great scope in the expansion of market in North America.

Roche Diagnostics, Johnson & Johnson, Abbott Laboratories, Novo Nordisk, Ascensia, Tandem and Terumo are the top companies in North American Diabetes Care Devices Market.

Avail discount @

About Us:

Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.


Abhishek Shukla

Sales Manager (International Business Development)

Market Data Forecast

Direct Line: +1-888-702-9626

Mobile: +91 998 555 0206


Visit MarketDataForecast Blog @

View latest Press Releases of MDF @

%d bloggers like this: